Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.

Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.

Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.

Hemerion Therapeutics

Maximilien Vermandel

This department oversees the organization's governance and strategic direction through board members.

Board Governance

This department ensures products meet quality standards through rigorous testing and validation processes.

Quality Assurance

This department focuses on the innovation and advancement of therapeutic solutions through scientific research and engineering.

Hemerion Therapeutics

Org chart

Teams

Board Governance

Quality Assurance

Research and Development

Offices

Hemerion Therapeutics

Org chart

Teams

Board Governance

Quality Assurance

Research and Development

Offices

Related companies